Tarbox Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-500
| Closed | -$39K | – | 231 |
|
|
2022
Q1 | $39K | Hold |
500
| – | – | 0.01% | 206 |
|
|
2021
Q4 | $44K | Hold |
500
| – | – | 0.01% | 240 |
|
|
2021
Q3 | $39K | Hold |
500
| – | – | 0.01% | 271 |
|
|
2021
Q2 | $42K | Sell |
500
-11
| -2% | -$924 | 0.01% | 266 |
|
|
2021
Q1 | $39K | Hold |
511
| – | – | 0.01% | 222 |
|
|
2020
Q4 | $45K | Hold |
511
| – | – | 0.01% | 204 |
|
|
2020
Q3 | $39K | Hold |
511
| – | – | 0.01% | 210 |
|
|
2020
Q2 | $63K | Hold |
511
| – | – | 0.02% | 163 |
|
|
2020
Q1 | $43K | Sell |
511
-489
| -49% | -$41.1K | 0.01% | 172 |
|
|
2019
Q4 | $85K | Hold |
1,000
| – | – | 0.02% | 143 |
|
|
2019
Q3 | $67K | Sell |
1,000
-20
| -2% | -$1.34K | 0.02% | 142 |
|
|
2019
Q2 | $87K | Hold |
1,020
| – | – | 0.03% | 133 |
|
|
2019
Q1 | $91K | Hold |
1,020
| – | – | 0.03% | 122 |
|
|
2018
Q4 | $87K | Sell |
1,020
-3
| -0.3% | -$256 | 0.04% | 120 |
|
|
2018
Q3 | $99K | Hold |
1,023
| – | – | 0.04% | 121 |
|
|
2018
Q2 | $96K | Buy |
1,023
+3
| +0.3% | +$282 | 0.04% | 123 |
|
|
2018
Q1 | $83K | Hold |
1,020
| – | – | 0.03% | 135 |
|
|
2017
Q4 | $91K | Hold |
1,020
| – | – | 0.04% | 130 |
|
|
2017
Q3 | $95K | Hold |
1,020
| – | – | 0.04% | 123 |
|
|
2017
Q2 | $93K | Hold |
1,020
| – | – | 0.05% | 113 |
|
|
2017
Q1 | $90K | Hold |
1,020
| – | – | 0.05% | 98 |
|
|
2016
Q4 | $84K | Buy |
1,020
+1,003
| +5,900% | +$82.6K | 0.05% | 84 |
|
|
2016
Q3 | $2K | Hold |
17
| – | – | ﹤0.01% | 418 |
|
|
2016
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 472 |
|
|
2016
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 486 |
|
|
2015
Q4 | – | Sell |
-10
| Closed | -$1K | – | 542 |
|
|
2015
Q3 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 459 |
|